Yang, Li <br/><br/>
Economic Evaluation of Sevelamer versus Calcium-based Binders in Treating Hyperphosphatemia among Patients with End-stage Renal Disease in China.  [electronic resource] 

 -  Clinical therapeutics  Nov 2016 
 - 2459-2467.e1 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1879-114X 
<br/><br/><label>Standard No.: </label>10.1016/j.clinthera.2016.09.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Calcium--therapeutic use<br/>Chelating Agents--therapeutic use<br/>China<br/>Cost-Benefit Analysis<br/>Humans<br/>Hyperphosphatemia--drug therapy<br/>Kidney Failure, Chronic--therapy<br/>Male<br/>Quality-Adjusted Life Years<br/>Sevelamer--therapeutic use<br/>Survival Analysis